These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20003255)

  • 1. Synthesis and expression of CDw75 antigen in human colorectal cancer.
    Costa-Nogueira C; Villar-Portela S; Cuevas E; Gil-Martín E; Fernández-Briera A
    BMC Cancer; 2009 Dec; 9():431. PubMed ID: 20003255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-free survival of colorectal cancer patients in relation to CDw75 antigen expression.
    Villar-Portela S; Muinelo-Romay L; Cuevas E; Gil-Martín E; Fernández-Briera A
    Pathobiology; 2011; 78(4):201-9. PubMed ID: 21778787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic evaluation of CDw75 antigen expression in colorectal adenocarcinomas.
    Elpek GO; Gelen T; Karpuzoglu G; Karpuzoglu T; Aksoy NH; Keles N
    Pathol Oncol Res; 2002; 8(3):175-82. PubMed ID: 12515997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of ST6Gal I activity in malignant and transitional tissue in human colorectal cancer.
    Vázquez-Martín C; Gil-Martín E; Fernández-Briera A
    Oncology; 2005; 69(5):436-44. PubMed ID: 16319516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic evaluation of CDw75 antigen expression in patients with gastric carcinoma.
    Elpek GO; Gelen T; Karpuzoğlu G; Karpuzoğlu T; Keles N
    J Pathol; 2001 Feb; 193(2):169-74. PubMed ID: 11180162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. sLea and sLex expression in colorectal cancer: implications for tumourigenesis and disease prognosis.
    Portela SV; Martín CV; Romay LM; Cuevas E; Martín EG; Briera AF
    Histol Histopathol; 2011 Oct; 26(10):1305-16. PubMed ID: 21870334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of tumor marker CDw75 and its clinical impact in gastric carcinoma].
    Li HX; Shen ZX; Tan SY
    Ai Zheng; 2003 Jan; 22(1):83-5. PubMed ID: 12561443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDw75 antigen expression in human gastric carcinoma and adjacent mucosa.
    David L; Nesland JM; Funderud S; Sobrinho-Simões M
    Cancer; 1993 Sep; 72(5):1522-7. PubMed ID: 8348485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
    Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
    Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression and significance of CD(276) and CD(133) in colorectal cancer and precancerous lesions].
    Lu GF; Huang LN; Ren JL; Hu GM; Zheng ZH; Wu JX; Zhu YP; Tang FA
    Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):450-453. PubMed ID: 29925132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of proteins with the CDw75 epitope in human colorectal cancer.
    Mariño-Crespo Ó; Fernández-Briera A; Gil-Martín E
    Oncol Lett; 2018 Jan; 15(1):580-587. PubMed ID: 29391890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential CXC receptor expression in colorectal carcinomas.
    Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
    Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDw75 antigen expression in breast lesions.
    Reed W; Erikstein BK; Funderud S; Lilleng R; Tvedt K; Nesland JM
    Pathol Res Pract; 1993 May; 189(4):394-8. PubMed ID: 7688897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
    Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
    World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition.
    Tang H; Guo Q; Zhang C; Zhu J; Yang H; Zou YL; Yan Y; Hong D; Sou T; Yan XM
    Int J Mol Med; 2010 Nov; 26(5):631-41. PubMed ID: 20878084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDw75 is a significant histopathological marker for gastric carcinoma.
    Shen L; Li HX; Luo HS; Shen ZX; Tan SY; Guo J; Sun J
    World J Gastroenterol; 2004 Jun; 10(11):1682-5. PubMed ID: 15162552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
    Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
    Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epithelia.
    Xi HQ; Zhang KC; Li JY; Cui JX; Zhao P; Chen L
    World J Surg Oncol; 2017 Apr; 15(1):90. PubMed ID: 28449687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.